CTNNB1 and neoplasm: However, significant tumor responses were observed at the 1mg/kg dosage in LNP-CTNNB1 treated mice as noted via H&E, IHC for Myc-tag and GS/Ki67, and magnetic resonance imaging (MRI) (Figure 1g; Figure S3a–d).